SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001279569-16-004156
Filing Date
2016-08-10
Accepted
2016-08-10 16:32:51
Documents
3
Period of Report
2016-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v446069_8k.htm 8-K 20753
2 EXHIBIT 99.1 v446069_ex99-1.htm EX-99.1 76089
3 GRAPHIC logo.jpg GRAPHIC 1839
  Complete submission text file 0001279569-16-004156.txt   100576
Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9
Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449
Cynapsus Therapeutics Inc. (Filer) CIK: 0001532079 (see all company filings)

IRS No.: 981226819 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37426 | Film No.: 161821887
SIC: 2834 Pharmaceutical Preparations